SciELO - Scientific Electronic Library Online

 
vol.22 número2Revisión y recomendaciones para el manejo de diarrea por Vibrio parahaemolyticusFaringitis aguda, ¿estreptocóccica? Empleo del estudio etiológico y de antimicrobianos en dos centros pediátricos universitarios índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

Compartir


Revista chilena de infectología

versión impresa ISSN 0716-1018

Resumen

FEHLMANN P., Elisa et al. Search of amantadine-resistance in influenza A strains isolated in Santiago, Chile, 2001-2002. Rev. chil. infectol. [online]. 2005, vol.22, n.2, pp.141-146. ISSN 0716-1018.  http://dx.doi.org/10.4067/S0716-10182005000200004.

Amantadine has been used for prevention and treatment of influenza A infection. It blocks the proton through the M2 ion channel. Drug-resistant viruses appear quickly when this therapy is used. Single amino acids changes in the H2 protein can confer resistance, being the most frequent one in position 31. Different methods to detect resistant strains have been described. The objectives were to determine the existence of amantadine resistance of influenza A strains isolated in a virologic laboratory in Santiago, Chile, between 2001-2002, and to validate a new molecular method to detect resistant strains. A PCR restriction fragment length polymorphism analysis was employed for the detection of resistant viruses. In 31 processed strains no mutation in the position 31 was found. This result supports that amantadine resistance is very low or absent in Chile. This could be explained by a limited use of this drug in the study population. This method could be used as a monitoring system to survey resistant viruses.

Palabras clave : Amantadine; Resistance; Influenza A virus; M2 protein.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons